Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030- Product Image

Sale

Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030

Report
199 Pages
October 2024
Region: Global
360iResearch™
ID: 5612994

UP TO €668EUR$697USD£555GBP OFF until Dec 31^st 2024

The Veterinary Pharmaceuticals Market grew from USD 37.46 billion in 2023 to USD 40.53 billion in 2024. It is expected to continue growing at a CAGR of 8.35%, reaching USD 65.71 billion by 2030.

The veterinary pharmaceuticals market encompasses the development, manufacturing, and distribution of medications designed for animal health, focusing on both companion animals and livestock. This sector is crucial for maintaining animal health, preventing zoonotic diseases, and supporting the global food supply chain. Applications include vaccines, antibiotics, parasiticides, and pain management treatments. The end-users primarily consist of veterinary clinics, animal farms, research institutions, and pet owners. Key growth drivers include the increasing pet ownership rates, rising demand for animal-derived food products, advancements in biopharmaceutical technologies, and heightened awareness of veterinary health and welfare. Furthermore, the integration of digital tools such as telemedicine and IoT in animal health monitoring offers potential growth opportunities. However, challenges include regulatory hurdles, high R&D costs, antibiotic resistance, and strict compliance requirements. There is also the increasing influence of consumer advocacy groups demanding transparency and sustainable practices in animal treatment. To seize new opportunities, firms should explore the development of next-generation biologics, including DNA vaccines and personalized medicine for pets, which address specific genetic disorders. Innovations in drug delivery systems, such as sustained-release injectables and oral solutions, can enhance treatment efficacy and compliance. Additionally, leveraging big data analytics for predictive health maintenance in livestock and predictive analytics for disease outbreaks could revolutionize the way services are delivered. Nonetheless, overcoming market challenges requires strategic partnerships with regulatory bodies to streamline approval processes and improve market access. Industry players should prioritize sustainable practices by developing eco-friendly products and consider reforms in production processes to address the environmental and resistance concerns. Looking forward, the market seems multidimensional with increasing convergence of technology and biology, presenting both challenges and novel pathways for companies committed to advancing animal health through transformative solutions.

Understanding Market Dynamics in the Veterinary Pharmaceuticals Market

The Veterinary Pharmaceuticals Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Growing incidence of diseases in livestock and companion animals, rising need for treatment and medications
- Increase in R&D activities for veterinary healthcare
Market Restraints
- Risk of recalls associated with veterinary drugs and vaccines
Market Opportunities
- Development of new and advanced veterinary pharmaceuticals
- Increasing investment by companies for the expansion of veterinary vaccine facilities
Market Challenges
- Concerns associated with the adverse effects of veterinary vaccine

Exploring Porter’s Five Forces for the Veterinary Pharmaceuticals Market

Porter’s Five Forces framework further strengthens the insights of the Veterinary Pharmaceuticals Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Veterinary Pharmaceuticals Market

External macro-environmental factors deeply influence the performance of the Veterinary Pharmaceuticals Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Veterinary Pharmaceuticals Market

The Veterinary Pharmaceuticals Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Veterinary Pharmaceuticals Market

The Veterinary Pharmaceuticals Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Veterinary Pharmaceuticals Market

The Veterinary Pharmaceuticals Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Aurora Pharmaceutical, Inc., Biogénesis Bagó S.A., Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma, China Animal Husbandry Industry Co., Ltd., Dechra Pharmaceuticals PLC, ECO Animal Health Group PLC, Elanco Animal Health Incorporated, Heska Corporation, Hester Biosciences Limited, Indian Immunologicals Ltd., Intas Pharmaceuticals Ltd., Laboratorio Drag Pharma Chile Invetec S.A., Merck & Co., Inc., Neogen Corporation, Norbrook Group, Phibro Animal Health Corporation, Teknofarma S.r.l., Vetoquinol Group, Vetpharma Animal Health S.L. by Insud Pharma S.L.U., Virbac S.A., Zendal Group, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

Products
- Drugs
  - Analgesics
  - Anti-Infectives
    - Antibiotics
    - Antifungals
  - Anti-Inflammatories
    - Non-Steroidal
    - Steroidal
  - Parasiticides
    - Ectoparasiticides
    - Endoparasiticides
- Medicinal Feed
  - Antibiotic Medicated Feed
  - Antiparasitic Medicated Feed
  - Growth Promoters
  - Nutritional Medicated Feed
  - Probiotic & Prebiotic Medicated Feed
- Vaccines
  - Inactivated Vaccines
  - Live Vaccines
Animal Type
- Companion Animals
  - Cats
  - Dogs
  - Horses
- Livestock Animals
  - Cattle
  - Poultry
  - Sheep & Goats
  - Swine
Mode of Administration
- Injectable
  - Intramuscular
  - Subcutaneous
- Oral
  - Capsules
  - Liquid Suspension & Syrup
  - Tablets
- Topical
  - Creams
  - Lotions
  - Ointments
Indications
- Chronic & Acute Pain Management
- Immunological Conditions
- Infectious Diseases
- Metabolic Disorders
- Neurological Disorders
- Orthopedic Disorders
- Parasitic Infections
- Reproductive Health
Distribution Channel
- Online Pharmacies
- Retail Pharmacies
- Veterinary Clinics
End User
- Animal Farms
- Pet Owners
- Veterinary Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - Massachusetts
    - New Jersey
    - New York
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of diseases in livestock and companion animals, rising need for treatment and medications
5.1.1.2. Increase in R&D activities for veterinary healthcare
5.1.2. Restraints
5.1.2.1. Risk of recalls associated with veterinary drugs and vaccines
5.1.3. Opportunities
5.1.3.1. Development of new and advanced veterinary pharmaceuticals
5.1.3.2. Increasing investment by companies for the expansion of veterinary vaccine facilities
5.1.4. Challenges
5.1.4.1. Concerns associated with the adverse effects of veterinary vaccine
5.2. Market Segmentation Analysis
5.2.1. Products: The growing demand for medicinal feed to improve animal health and productivity
5.2.2. Animal Type: Growing need for veterinary pharmaceuticals in livestock animals owing to disease control and productivity enhancement
5.2.3. Mode of Administration: Increasing utilization of capsules for ensuring dosage accuracy
5.2.4. Indications: Emerging focus on the introduction of drugs advancing treatments for metabolic disorders
5.2.5. Distribution Channel: Growing consumer preference for online pharmacies owing to their convenience and wide range of products
5.2.6. End User: Expanding applications of veterinary pharmaceuticals by pet owners
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Veterinary Pharmaceuticals Market, by Products

6.1. Introduction
6.2. Drugs
6.2.1. Analgesics
6.2.2. Anti-Infectives
6.2.2.1. Antibiotics
6.2.2.2. Antifungals
6.2.3. Anti-Inflammatories
6.2.3.1. Non-Steroidal
6.2.3.2. Steroidal
6.2.4. Parasiticides
6.2.4.1. Ectoparasiticides
6.2.4.2. Endoparasiticides
6.3. Medicinal Feed
6.3.1. Antibiotic Medicated Feed
6.3.2. Antiparasitic Medicated Feed
6.3.3. Growth Promoters
6.3.4. Nutritional Medicated Feed
6.3.5. Probiotic & Prebiotic Medicated Feed
6.4. Vaccines
6.4.1. Inactivated Vaccines
6.4.2. Live Vaccines

7. Veterinary Pharmaceuticals Market, by Animal Type

7.1. Introduction
7.2. Companion Animals
7.2.1. Cats
7.2.2. Dogs
7.2.3. Horses
7.3. Livestock Animals
7.3.1. Cattle
7.3.2. Poultry
7.3.3. Sheep & Goats
7.3.4. Swine

8. Veterinary Pharmaceuticals Market, by Mode of Administration

8.1. Introduction
8.2. Injectable
8.2.1. Intramuscular
8.2.2. Subcutaneous
8.3. Oral
8.3.1. Capsules
8.3.2. Liquid Suspension & Syrup
8.3.3. Tablets
8.4. Topical
8.4.1. Creams
8.4.2. Lotions
8.4.3. Ointments

9. Veterinary Pharmaceuticals Market, by Indications

9.1. Introduction
9.2. Chronic & Acute Pain Management
9.3. Immunological Conditions
9.4. Infectious Diseases
9.5. Metabolic Disorders
9.6. Neurological Disorders
9.7. Orthopedic Disorders
9.8. Parasitic Infections
9.9. Reproductive Health

10. Veterinary Pharmaceuticals Market, by Distribution Channel

10.1. Introduction
10.2. Online Pharmacies
10.3. Retail Pharmacies
10.4. Veterinary Clinics

11. Veterinary Pharmaceuticals Market, by End User

11.1. Introduction
11.2. Animal Farms
11.3. Pet Owners
11.4. Veterinary Hospitals

12. Americas Veterinary Pharmaceuticals Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Veterinary Pharmaceuticals Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Veterinary Pharmaceuticals Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape

15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Dechra Pharmaceuticals to acquire Invetx to enhance veterinary therapeutics portfolio
15.3.2. TechInvention and Botswana Institute partner to revolutionize veterinary vaccine production
15.3.3. Merck Animal Health introduces innovative RNA-particle Canine Flu vaccine
15.3.4. Huvepharma Expands with EUR 72 million veterinary vaccine plant to boost global supply and innovation
15.3.5. Virbac strengthens position in Japanese market with Sasaeah acquisition
15.3.6. FDA approvals enhance veterinary treatments for heart and respiratory conditions
15.3.7. Impact of EVML on global veterinary medicine accessibility and AMR mitigation
15.3.8. Zendal and CSIC unveil innovative Neoleish vaccine to combat canine leishmaniasis
15.3.9. Merck Animal Health acquires Elanco’s aqua business to strengthen aquaculture presence
15.3.10. Huateng Pharma expands with fluralaner and sarolaner launch, revolutionizing veterinary pharmaceuticals
15.3.11. ENTOD Pharmaceuticals expands into veterinary market with "FUR by ENTOD" division
15.3.12. Indian Immunologicals Ltd (IIL) invests INR 700 crore in Hyderabad vaccine plant to boost livestock disease eradication
15.3.13. Virbac acquires stake in Globion to boost avian vaccine market presence in India
15.3.14. Strategic collaboration between Pirbright Institute and USask's VIDO to boost vaccine innovation and pandemic readiness
15.4. Strategy Analysis & Recommendation
15.4.1. Dechra Pharmaceuticals PLC
15.4.2. Zoetis Inc.
15.4.3. Ceva Santé Animale
15.4.4. Boehringer Ingelheim GmbH

List of Figures

FIGURE 1. VETERINARY PHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. VETERINARY PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
FIGURE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. VETERINARY PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. VETERINARY PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. VETERINARY PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. VETERINARY PHARMACEUTICALS MARKET DYNAMICS
TABLE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NON-STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIPARASITIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROWTH PROMOTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NUTRITIONAL MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PROBIOTIC & PREBIOTIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIQUID SUSPENSION & SYRUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CHRONIC & ACUTE PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY IMMUNOLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 131. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 132. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 133. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 134. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 135. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 136. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 137. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 138. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 139. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 140. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 142. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 143. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 144. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 145. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 148. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 150. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 151. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 152. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 153. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 154. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 155. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 159. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 160. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 161. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 202. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 218. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 219. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 220. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 221. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 222. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 223. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 224. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 225. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 226. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 227. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 229. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 230. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 231. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 232. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 235. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 236. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 237. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 238. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 239. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 240. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 241. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 242. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 243. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 244. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 245. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 246. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 247. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 248. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 249. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 252. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 253. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 254. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 255. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 256. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 257. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 258. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 259. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 269. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 270. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 271. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 272. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 273. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 274. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 275. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 276. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 277. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 278. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 280. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 281. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 282. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 283. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 286. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 287. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 288. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 289. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 290. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 291. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 292. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 293. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 294. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 303. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 304. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 305. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 306. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 307. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 308. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 309. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 310. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 311. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 312. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 313. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 314. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 315. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 316. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 317. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 320. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 321. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANT

Companies Mentioned

The leading players in the Veterinary Pharmaceuticals Market, which are profiled in this report, include:

Aurora Pharmaceutical, Inc.
Biogénesis Bagó S.A.
Biovac Ltd.
Boehringer Ingelheim International GmbH
Ceva Santé Animale
Chanelle Pharma
China Animal Husbandry Industry Co., Ltd.
Dechra Pharmaceuticals PLC
ECO Animal Health Group PLC
Elanco Animal Health Incorporated
Heska Corporation
Hester Biosciences Limited
Indian Immunologicals Ltd.
Intas Pharmaceuticals Ltd.
Laboratorio Drag Pharma Chile Invetec S.A.
Merck & Co., Inc.
Neogen Corporation
Norbrook Group
Phibro Animal Health Corporation
Teknofarma S.r.l.
Vetoquinol Group
Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
Virbac S.A.
Zendal Group
Zoetis Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	199
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 40.53 Billion
Forecasted Market Value ( USD ) by 2030	$ 65.71 Billion
Compound Annual Growth Rate	8.3%
Regions Covered	Global
No. of Companies Mentioned	25

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3397EUR$3,545USD£2,826GBP €3774EUR$3,939USD£3,140GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6009EUR$6,272USD£4,999GBP €6677EUR$6,969USD£5,555GBP

Understanding Market Dynamics in the Veterinary Pharmaceuticals Market

Exploring Porter’s Five Forces for the Veterinary Pharmaceuticals Market

Applying PESTLE Analysis to the Veterinary Pharmaceuticals Market

Analyzing Market Share in the Veterinary Pharmaceuticals Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Veterinary Pharmaceuticals Market

Strategic Recommendations for Success in the Veterinary Pharmaceuticals Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Veterinary/Animal Vaccines Market by Type, Disease, Technology - Global Forecast 2025-2030

Global Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Forecast 2024-2030

Global Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle), Dosage Form (Oral Powders, Injections), Drug Class, Region, and Segment Forecasts, 2024-2030

Veterinary Antibiotics Global Market Report 2024

Companion Animal Veterinary Vaccines Global Market Report 2024